PolyBall: A new adsorbent for the efficient removal of endotoxin from biopharmaceuticals.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 06 2019
Historique:
received: 25 02 2019
accepted: 06 06 2019
entrez: 22 6 2019
pubmed: 22 6 2019
medline: 21 10 2020
Statut: epublish

Résumé

The presence of endotoxin, also known as lipopolysaccharides (LPS), as a side product appears to be a major drawback for the production of certain biomolecules that are essential for research, pharmaceutical, and industrial applications. In the biotechnology industry, gram-negative bacteria (e.g., Escherichia coli) are widely used to produce recombinant products such as proteins, plasmid DNAs and vaccines. These products are contaminated with LPS, which may cause side effects when administered to animals or humans. Purification of LPS often suffers from product loss. For this reason, special attention must be paid when purifying proteins aiming a product as free as possible of LPS with high product recovery. Although there are a number of methods for removing LPS, the question about how LPS removal can be carried out in an efficient and economical way is still one of the most intriguing issues and has no satisfactory solution yet. In this work, polymeric poly-ε-caprolactone (PCL) nanoparticles (NPs) (d

Identifiants

pubmed: 31222053
doi: 10.1038/s41598-019-45402-w
pii: 10.1038/s41598-019-45402-w
pmc: PMC6586805
doi:

Substances chimiques

Biological Products 0
Caproates 0
Lactones 0
Lipopolysaccharides 0
caprolactone 56RE988L1R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8867

Références

J Clin Microbiol. 1981 Jan;13(1):49-53
pubmed: 7007429
PLoS One. 2017 Mar 29;12(3):e0173778
pubmed: 28355240
Methods Mol Biol. 2012;899:265-75
pubmed: 22735959
Comb Chem High Throughput Screen. 2004 May;7(3):239-49
pubmed: 15134530
Nanotechnology. 2016 Jul 15;27(28):285601
pubmed: 27254407
Biomaterials. 2005 Dec;26(34):6811-7
pubmed: 16019062
Biotechnol Bioeng. 2015 Aug;112(8):1714-9
pubmed: 25728530
Biotechnol J. 2012 Dec;7(12):1509-16
pubmed: 23081824
Science. 1983 Feb 11;219(4585):632-7
pubmed: 6337396
J Pharm Sci. 2002 Feb;91(2):543-58
pubmed: 11835212
Curr Opin Biotechnol. 2001 Apr;12(2):208-11
pubmed: 11287239
Protein Expr Purif. 2007 Feb;51(2):147-56
pubmed: 16908190
Microbiology (Reading). 2009 Mar;155(Pt 3):979-988
pubmed: 19246768
J Ind Microbiol Biotechnol. 2012 Mar;39(3):383-99
pubmed: 22252444
Microbiol Res. 2015 Jan;170:1-9
pubmed: 25458555
J Biomater Sci Polym Ed. 2018 May - Jun;29(7-9):863-893
pubmed: 29053081
Biomed Res Int. 2013;2013:312709
pubmed: 24455685
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 May 15;1085:1-12
pubmed: 29625371
J Chromatogr A. 2005 Mar 25;1069(1):3-22
pubmed: 15844479
Vaccine. 2001 Feb 8;19(13-14):1747-52
pubmed: 11166900
Carbohydr Polym. 2016 Jan 20;136:12-8
pubmed: 26572323
Anal Biochem. 2012 May 15;424(2):124-6
pubmed: 22370278
Artif Cells Nanomed Biotechnol. 2018 Feb;46(1):185-191
pubmed: 28332430
J Mater Chem B. 2017 Nov 7;5(41):8219-8227
pubmed: 32264465
Water Res. 2002 May;36(10):2627-35
pubmed: 12153030
Ann N Y Acad Sci. 2007 Jan;1096:1-17
pubmed: 17405910
Biotechnol Bioeng. 2011 Jan;108(1):59-68
pubmed: 20672251
Pediatr Int. 2016 Dec;58(12):1346-1347
pubmed: 27061874
J Med Case Rep. 2017 Feb 22;11(1):49
pubmed: 28222811
J Crit Care. 2014 Oct;29(5):728-32
pubmed: 24798345
Methods Enzymol. 2009;463:405-14
pubmed: 19892185
J Pharm Pharm Sci. 2007;10(3):388-404
pubmed: 17727802
Colloids Surf B Biointerfaces. 2014 Aug 1;120:81-7
pubmed: 24905681
Biotechnol Adv. 2013 Jul-Aug;31(4):450-65
pubmed: 23357364
J Microbiol Methods. 2017 Jan;132:153-159
pubmed: 27913133
Anal Biochem. 1980 May 15;104(2):300-10
pubmed: 7446957
Biomaterials. 1999 Jul;20(14):1277-83
pubmed: 10403045
Nano Lett. 2014 Jan 8;14(1):1-5
pubmed: 23367876
Nephrol Dial Transplant. 2017 Jan 1;32(1):24-31
pubmed: 27387474
Langmuir. 2018 Jun 26;34(25):7396-7403
pubmed: 29806945
Infect Immun. 1972 Jul;6(1):27-31
pubmed: 4628861
Methods Enzymol. 1990;182:24-38
pubmed: 2314240
Drug Deliv. 2008 Sep;15(7):409-16
pubmed: 18712617
Sci Rep. 2018 Feb 5;8(1):2384
pubmed: 29402892
Water Sci Technol. 2016 Dec;74(11):2611-2619
pubmed: 27973365
J Chromatogr A. 2012 Nov 2;1262:169-79
pubmed: 23026261
Water Sci Technol. 2009;60(6):1497-505
pubmed: 19759452
Int J Nanomedicine. 2015 Mar 18;10:2155-71
pubmed: 25834431
Appl Microbiol Biotechnol. 2006 Sep;72(2):211-22
pubmed: 16791589
Nat Biotechnol. 2010 Sep;28(9):917-24
pubmed: 20829826
J Chromatogr A. 2002 Apr 5;952(1-2):13-27
pubmed: 12064524
Biochemistry. 1966 Feb;5(2):467-77
pubmed: 5942950
Biotechnol Bioeng. 2007 Mar 1;96(4):768-79
pubmed: 16817242
Nature. 2005 Sep 29;437(7059):640-7
pubmed: 16193038
Bull Environ Contam Toxicol. 2009 Jun;82(6):732-7
pubmed: 19280089
J Sep Sci. 2012 Nov;35(22):3139-48
pubmed: 22753361
Drug Discov Today. 2014 May;19(5):590-601
pubmed: 24246684
Biotechnol Prog. 2014 Nov-Dec;30(6):1497-501
pubmed: 25079968
Blood Purif. 2017;44(3):193-197
pubmed: 28601867
Drug Res (Stuttg). 2016 Oct;66(10):506-519
pubmed: 27403578

Auteurs

Sidharth Razdan (S)

Department of Chemical and Biochemical Engineering Missouri University of Science and Technology, Rolla, MO, 65409, USA.

Jee-Ching Wang (JC)

Department of Chemical and Biochemical Engineering Missouri University of Science and Technology, Rolla, MO, 65409, USA.

Sutapa Barua (S)

Department of Chemical and Biochemical Engineering Missouri University of Science and Technology, Rolla, MO, 65409, USA. baruas@mst.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH